Drug Type Molecular glue |
Synonyms- |
Target |
Mechanism PRKN activators(parkin RBR E3 ubiquitin protein ligase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | CA | 19 Sep 2024 | |
Parkinson Disease | Preclinical | US | 19 Sep 2024 |